Topoisomerase I Inhibitors Pair With PARP Drugs Against Resistant Ovarian Cancer
A screen of over 1400 FDA-approved compounds identified topoisomerase I inhibitors as the most effective partners for PARP inhibitors in ...
Tag: olaparib resistance
CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer
In a groundbreaking study, researchers have uncovered the role of a specific circular RNA, CircRNA14781, in contributing to olaparib resistance ...
